Introduction: This work was done to determine phytochemical content, antioxidant activity, and hepatoprotective effects of Zizyphus xylopyrus leaves extracts against carbon tetrachloride-induced hepatotoxicity in in vitro and in vivo models. Materials and Methods: The total flavonoids content (TFC), total phenolic content (TPC), and total tannin content (TTC) were determined using quercetin and tannic acid equivalents, as standard while antioxidant activities of extracts were determined using the standard in vitro methods. All the extracts subjected to in-vitro HepG2 cell line study as well as to evaluate in vivo hepatoprotective effects against carbon tetrachloride (CCl 4 ) intoxicated rats. Results: Among all extracts, ethyl acetate extract (EAE) possess potent antioxidant activity, viz., ferric reducing ability of plasma (abs = 0.379 ± 0.07), 2,2-diphenyl-1-picrylhydrazyl (inhibitory concentration 50% [IC 50 ]: 103.50 ± 2.05 µg/mL), OH
INTRODUCTION
T he liver plays a pivotal role in the metabolism and is continuously exposed to xenobiotics, environmental pollutants and chemotherapeutic agents, which leads to either an increase in free radicals or reactive oxygen species (ROS) generation and/or a decrease in the antioxidant defense mechanisms/or directly affect the biochemistry ORIGINAL ARTICLE Modi of cell by interacting with cellular macromolecules. [1, 2] Oxidative stress and inflammation are well-noted features in the pathogenesis of hepatic disorders. The percentage of liver toxicity due to various toxicants exposures is much higher in developing countries like India (8-30%) as compared to the advanced countries (2-3%). Approximately, 20000 deaths and 250000 new cases have been reported every year worldwide. [3, 4] The available synthetic drugs such as interferon and corticosteroids for treatment of hepatic disease are expensive and may cause further damage.
Physicians and patients are in need of effective therapeutic agents with a low incidence of side-effects. [5] Therefore, considerable attention is focused on sighting the hepatoprotective agents from plants based medicines, which can attenuate the free radicals resulting in the reduction of the oxidative damage to the biomolecules. Various reports suggested that phytochemicals such as phenolics, alkaloids, terpenoids, isoterpenoids, and quinines possessed protective effect in free radical associated disorders. [6, 7] Natural polyphenols such as flavonoids (e.g., Quercetin, kaempferol, and rutin) and other phenolic acids (hydroxyl cinnamic acid derivatives, gallic acid, and catechins) are potent antioxidants exhibiting hepatoprotective effect and are used in the treatment of chronic liver injuries. [8, 9] Carbon tetrachloride (CCl 4 ) is one of the hazardous chemicals, which undergoes enzymatic activation by various cytochromes such as CYP2E1, CYP2B1 or CYP2B2 and possibly CYP3A, for generating the trichloromethyl radical (CCl 3 • ), which binds to the cellular molecules (i.e., Nucleic acid, protein, and lipid) and impairs the crucial cellular processes such as lipid metabolism (fatty degeneration-steatosis). This radical reacts with molecular oxygen to form trichloromethylperoxy radical (CCl 3 OO • ) and initiates the lipid peroxidation (LPO), which affects the permeability of mitochondria, endoplasmic reticulum and plasma membrane, resulting in the loss of cellular calcium sequestration, homeostasis and subsequent cell damage. [10, 11] The genus Ziziphus (Rhamnaceae) comprises about 100 species of evergreen tree known for its various pharmacological activities, i.e., hypoglycemic, hypotensive, antimicrobial, antioxidant, immunostimulant, anti-inflammatory, and hepatoprotective activity. [12] Ziziphus xylopyrus (Retz.) Willd, a large, straggling shrub, is commonly distributed throughout the North-Western India, Pakistan, and China. Various reports claimed the traditional uses of the different parts of the plant for the treatment of different ailments such as obesity, urinary troubles, diabetes, skin infections, fever, diarrohea, insomnia, digestive, and liver disorders. [13] Different types of the plant extracts have been advocated pharmacologically to exhibit the antisteroidogenic, [14] anticonvulsant, antinociceptive, antiinflammatory, [15] antidepressant [16] as well as wound healing activity. [17] [18] [19] Functional foods are foods thought to supply an additional benefit beyond meeting micronutrient or macronutrient needs, such as reducing oxidative stress, improving longevity, or lowering some disease risk factor. [8] Z. xylopyrus leaves were reported to contain flavonoids, viz., Quercetin and querceitrin, [20] which can ameliorate oxidative stressmediated liver damage. It is also used in Aragvadhadi Kvath Churna and Abharak Bhashma formulations. [21, 22] The link between antioxidant and hepatoprotective mechanisms has been previously established.
[23] Therefore, various parts of Z. xylopyrus exhibit potential to be included as active component of functional food. [24] However, till date, no attempt has been made to determine the phytochemical contents, antioxidant activity, and hepatoprotective potential of Z. xylopyrus leaves. In this regard, this study was aimed to determine the antioxidant activity as well as pharmacological evaluation of the protective and curative effect of different extracts of Z. xylopyrus leaves against CCl 4 induced hepatic injury.
MATERIALS AND METHODS

Chemicals and Reagents
Quercetin, gallic acid, vitamin C, trichloroacetic acid, thiobarbituric acid (TBA), nitro blue tetrazolium (NBT), sodium nitroprusside, hydroxylamine hydrochloride, penicillin, and Streptomycin were purchased from SigmaAldrich, Mumbai. The CCl 4 , Folin-Ciocalteu reagents (FCR), 1-napthylethylenediamine dihydrochloride, sulfanilamide, and ortho phosphoric acid were purchased from SD Fines Chemicals Pvt. Ltd., Mumbai. Trypsin, Dulbecoo's Modified Eagle's Medium (DMEM), dimethylsulfoxide (DMSO), Trypan blue, ethylenediaminetetraacetic acid (EDTA), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) were purchased from Bioworld, Mumbai and Hi-Media, Bengaluru, respectively. The Silymarin was received from Micro Lab, Baddi as gift sample. All other chemicals and solvents of analytical grade used in this study were procured from local supplier.
Plant Material Collection, Authentication, and Extraction
Fresh leaves of Z. xylopyrus were collected from plants growing in Talchini, Sagar (Madhya Pradesh), India in June 2012. The plant specimen was authenticated by Prof. Pradeep Tiwari, Department of Botany, Dr. H. S. Gour Central University, Sagar (Madhya Pradesh), India. A voucher specimen (Her/Bot/02/49/04) was prepared and deposited in the herbarium of the department. Dried powdered leaves of Z. xylopyrus were extracted successively with petroleum ether (40-60°C), chloroform, ethyl acetate and ethanol by hot extraction process. The marc was suspended in distilled water, macerated for 48 h and filtered. All the filtrates were dried under vacuum using rotary evaporator (Superfit Pvt Ltd., Mumbai, India) at 40 ± 2°C to obtained petroleum ether extract (PEE) (5.18% w/w), chloroform extract (CHE) (2.0% w/w), ethyl acetate extract (EAE) (1.69% w/w), ethanol extract (EtOHE) (7.98% w/w), and aqueous extract (AQE) (6.23% w/w).
Determination of Phytoconstituents
Preliminary phytochemical screening
The PEE, CHE, EAE, EtOH, and AQE extracts of Z. xylopyrus were subjected to determine the presence of various phytoconstituents such as alkaloids, glycosides, flavonoids, tannins, phytosterols, carbohydrate, and amino acids using previously reported qualitative chemical tests. [25] Total flavonoid content (TFC) Determination of TFC was based on measurement of the intensity of red color complex formed due to reaction between flavonoids and aluminum trichloride (AlCl 3 ). [26] Briefly, the AlCl 3 -methanolic solution (1 mL, 2% w/v) was mixed to various diluted extracts or standard (1 mL) and allowed to stand for 1 h at 25 ± 2°C before the absorbance was measured at λ max 420 nm against blank using ultravioletvisible (UV-Vis) spectrophotometer (Shimadzu 1800, Kyoto, Japan). Extract samples were evaluated at a final concentration of 1 mg/mL. The TFC was compared to quercetin equivalent (QE) (mg/g of extract) using the regression equation y = 0.00036x + 0.01768, r 2 = 0.9798, where x is the absorbance and y is the QE.
Total phenolic content (TPC) and total tannin content (TTC)
The TPC was determined by the reported Folin-Ciocalteu method, while TTC was estimated by precipitating tannins with gelatin. [27] Briefly, various extracts (1 mL, 1% w/v) were mixed with FCR (10 mL, previously diluted with distilled water in 1:10 ratio), vortexed and set aside for 5 min, then sodium carbonate solution (10 mL, 7% w/v) was added and diluted up to 25 mL with distilled water. The mixture was allowed to stand for 1.5 h at 25 ± 2°C and absorbance was measured at λ max 765 nm against blank using UV-Vis spectrophotometer (Shimadzu 1800, Kyoto, Japan).
For the estimation of non-tannin phenolics, the extract (2 mL) was mixed with gelatin solution (100 mg/mL of distilled water) and allowed to stand for 15 min at 4°C, vortexed and filtered through Whatman filter paper no.1. The filtrate (0.5 mL) was diluted with distilled water (up to 1 mL) and non-tannin phenolics were estimated by the similar method as used for TPC. The TTC of extracts was determined by subtracting non-tannin phenolics from the TPC. The results were compared to gallic acid equivalent (GAE) (mg/g of extract) using the regression equation y = 0.01695x + 0.14004, r 2 = 0.9895, where x is the absorbance and y is the GAE.
Determination of Antioxidant Activity
Ferric reducing ability of plasma (FRAP) assay
The ferric ion reducing power of extracts was determined by measuring the absorbance of chromophore.
[28] Different concentrations of extracts or standard, vitamin C (1 mL, 20-200 µg/mL) were mixed with phosphate buffer (2.5 mL, 0.2 M, pH 6.6), potassium ferric cyanide (2.5 mL, 1% w/v) and incubated at 50 ± 2°C for 20 min. Trichloroacetic acid (2.5 mL, 10% w/v) was added to the mixture and centrifuged at 3000 rpm for 10 min. The upper layer of the solution (2.5 mL) was separated and mixed with 2.5 mL of distilled water and ferric chloride (0.5 mL, 0.1% w/v). Then, the absorbance was measured at λ max 700 nm using UV-Vis spectrophotometer (Shimadzu 1800, Kyoto, Japan).
DPPH radical scavenging assay
The DPPH° radical scavenging ability of extracts was determined by measuring the intensity of yellow colored complex formed due to reaction between proton donar and DPPH° radical. [29] In short, the methanolic solution of DPPH (3 mL, 0.01 mM) was mixed with extracts or vitamin C (3 mL, 10-200 µg/mL) and incubated for 30 min in the dark. The absorbance of DPPH solution was measured at λ max 517 nm using UV-Vis spectrophotometer (Shimadzu 1800, Kyoto, Japan). The DPPH° radical scavenging ability was calculated using the following equation:
Where, A 0 is the absorbance of the control and A t is the absorbance of the sample.
Hydroxyl radical scavenging assay
Hydroxyl radicals (OH • ) scavenging ability of the extracts was determined by measuring the intensity of hydroxylated salicylate complex formed by the reaction of OH
• radical and sodium salicylate. [26] The reaction mixture containing ferrous sulfate (1 mL, 1.5 mM), hydrogen peroxide (H 2 O 2 ) (0.7 mL, 6 mM), sodium salicylate (0.3 mL, 20 mM), and varying concentrations of extracts or vitamin C (1 mL, 10-200 µg/mL) were incubated for 1 h at 37 ± 2°C. After incubation absorbance of the reaction mixture was measured at λ max 562 nm using UV-Vis spectrophotometer (Shimadzu 1800, Kyoto, Japan). The OH
• radical scavenging ability was calculated using the Equation 1.
Nitric oxide (NO
• ) radical scavenging assay
The determination of NO • scavenging ability of the extracts is based on the inhibition of NO
• radical generated from sodium nitroprusside in phosphate buffer saline solution by Griess reagent (1% sulfanilamide, 2% orthophosphoric acid, and 0.1% naphthyl ethylenediamine dihydrochloride). [30] Briefly, sodium nitroprusside (0.6 mL, 5 mM) solution was mixed with and without varying the concentration of the extracts or vitamin C (2 mL, 10-200 µg/mL) and incubated at 25 ± 2°C for 5 h. Incubated solution (2 mL) was mixed with equal volume of Griess reagent and absorbance of the purple colored azo dye chromophore was measured at λ max 546 nm using UV-Vis spectrophotometer (Shimadzu 1800, Kyoto, Japan). The NO• radical scavenging ability was calculated using the Equation 1.
Superoxide radical scavenging assay
Superoxide radical (O 2 − ) scavenging activity of extracts was measured by reported NBT reagent method. This method is based on the generation of O 2 − by auto-oxidation of hydroxylamine hydrochloride in the presence of NBT, which gets reduced to nitrite. The nitrite ion in the presence of EDTA produced a color that was measured at λ max 560 nm. [31] Sodium carbonate (1 mL, 50 mM), NBT (0.4 mL, 24 mM), and EDTA (0.2 mL, 0.1 mM) solutions were added in the test samples of extracts or vitamin C (1 ml, 10-200 µg/mL) and immediately absorbance was measured at λ max 560 nm. The addition of hydroxylamine hydrochloride (0.4 mL, 1 mM) initiated the reaction, incubated at 25 ± 2°C for 15 min, then absorbance was measured at λ max 560 nm. The scavenging activity of O 2 − was calculated by Equation 1.
Inhibition of lipid peroxidation in rat liver homogenate
Inhibition of lipid peroxidation activity of extracts was determined by measuring the intensity of pink colored complex formed by the reaction between malondialdehyde and TBA. [32, 33] Swiss albino rats (180-240 g) of either sex were sacrificed, and their livers were dissected out, washed properly with potassium chloride solution (0.15 M), homogenized and centrifuged at 3000 rpm for 10 min at 40 ± 2°C and discarded the precipitate. In liver homogenate (1 mL, 1% w/v), ferrous chloride (FeCl 2 ) (0.5 mL, 0.5 mM), H 2 O 2 (0.5 mL, 0.5 mM), and various concentrations of extracts or vitamin C (1 mL, 20-150 µg/mL) were added and incubated at 37 ± 2°C for 60 min. After incubation 1 mL of each trichloroacetic acid (15%) and TBA (0.67%) were added in reaction mixture, heated on boiling water bath for 25 min. Intensity of pink color formed was measured at λ max 535 nm. Percent inhibition of LPO was calculated using Equation 1.
Determination of Hepatoprotective Effect
In vitro hepatoprotective effect on HepG2 cell line against CCl 4 -induced damage
Human live hepatoma cells (HepG2) were procured from National Center for Cell Science, Pune, India. The HepG2 cells (1 × 10 5 cells/T25 flask) were seeded and cultured in DMEM containing fetal bovine serum (10%), penicillin (100 IU/mL) and streptomycin (0.1 µg/mL) and incubated in an humidified 5% CO 2 atmosphere at 37 ± 2°C for 24 h for more than 80% confluence. Cells were passaged by trypsinization of subconfluent culture using trypsin phosphate versene glucose solution containing trypsin (0.2% w/v), EDTA (0.02% w/v), and glucose (0.05% w/v) in phosphate buffer saline.
The cell viability determined by 3-(4,5 dimethyl thiazole-2 yl)-2,5-diphenyl tetrazolium bromide (methylthiazole tetrazolium [MTT]) cytotoxicity assay is based on cleavage of tetrazolium salt to a blue formazan derivative by living cells and reflects the mitochondrial activity. [34] Briefly, HepG2 cells (3 × 10 6 cells/well) were maintained in different groups in 96 well culture plates. Solutions of CCl 4 (1% v/v), silymarin, and extracts were prepared in serum free DMEM containing DMSO (0.1% v/v). After removing the media normal control group (Group I) cells were treated with 100 µl serum free DMEM containing DMSO (0.1% v/v) while toxicant control (Group II) and standard control (Group III) were treated with 100 µl of CCl 4 (1% v/v) and 100 µl silymarin of varying concentrations (50,100, 150, 200, 250 µg/mL), respectively. Treatment groups (Group IV-VIII) cells were treated with 100 µl of CCl 4 ( 1% v/v) and 100 µl of PEE, CHE, EAE, EtOHE and AQE with different concentrations (50,100, 150, 200, 250 µg/mL), respectively. After 2 h, serum free DMEM (100 µl) was added in each group for next 24 h. At the end of incubation period, MTT solution (20 µl, 5 mg/mL) was added, shake gently and incubated for 3 h in 5% CO 2 atmosphere at 37 ± 2°C and supernatant was removed. MTT is reduced by mitochondrial dehydrogenase activity in metabolically active cells to form insoluble formazan crystals. Then, isopropanol (50 µL) was added for solubilizing the formazan crystals. Absorbance was measured at 540 nm using microplate reader (Thermo Scientific, USA). The absorbance given by untreated cells was taken as 100% cell survival, and the relative (%) cell viability was calculated using following formula: % Cell viability = (Abs control −Abs sample )/Abs control × 100
Where, Abs control is the absorbance of control sample and Abs sample is the absorbance of test sample.
In vivo hepatoprotective effects
Animals
In the present investigation, the Swiss albino rats of either sex, weighing between 180 and 240 g were used. The animals were procured from College of Veterinary Sciences and Animal Husbandry, Mhow, Madhya Pradesh, India. Animals were allowed to acclimatize for 2 weeks before commencing the study and maintained under standard laboratory conditions (25 ± 2°C temperature, 45-65% relative humidity and 12 h light and 12 h dark cycle). The animals were fed with standard laboratory animal feed and water ad libitum throughout the study. The animal experimental protocols were duly approved by the Institution Animal Ethical Committee (IAEC No.1546/PO/E/S/11/CPCSEA).
Acute oral toxicity
Acute oral toxicity was performed according to Organization for Economic Co-operation and Development guideline No. 423. [35] Female rat fasted overnight, accessing water ad libitum were used in this study. The extract was administered orally at a dose of 300 mg/kg body weight, and the animals were observed for mortality or any abnormal behavior for first 24 h, then for up to next 14 days. The procedure was repeated at a dose of 2000 mg/kg body weight to determine the median lethal dose.
Direct method
Swiss albino rats used for this study were divided into 18 groups containing six rats in each group. The CCl 4 is diluted in olive oil (1:1) while suspension of silymarin as well as extracts were prepared in 2% v/v solution of Tween 80, which were used in prophylactic and curative studies. [36, 37] Prophylactic study Group I received only the vehicle, Tween 80 (1 mL/kg body weight/day) orally for 12 days. Groups II-XVIII received orally Tween 80 (1 mL/kg body weight/day), silymarin (100 mg/kg body weight/day) as well as the extracts at dose of 100, 200 and 400 mg/kg body weight, respectively for the first 7 days followed by intraperitoneal (i.p.) injections of CCl 4 in olive oil (1:1) at a dose of 0.5 mL/kg body weight for the next 5 days (i.e. a total of 12 days). The treatments (vehicle, silymarin, and extracts) were given daily while CCl 4 was given on alternate days, i.e. on 8 th , 10 th and 12 th day.
Curative study Group I received only the vehicle, Tween 80 (1 mL/kg body weight/day) orally for 12 days. Groups II-XVIII received i.p. injection of CCl 4 in olive oil (1:1) at a dose of 0.5 mL/kg body weight for 5 days and then orally administered Tween 80 (1 mL/kg body weight/day), silymarin (100 mg/kg body weight/day), as well as the extracts at dose of 100, 200 and 400 mg/kg body weight, respectively, for next 7 days (i.e. a total of 12 days). The treatments (vehicle, silymarin, and extracts) were given daily while CCl 4 was given on alternate days, i.e. on 1 st , 3 rd and 5 th day.
Hepatoprotective effect (H) expressed as percent hepatoprotection was calculated using following equation:
Where, T is the mean value of drug and CCl 4 treatment, C is the mean value of CCl 4 treatment alone and V is the mean value of vehicle treatment.
Assessment of hepatoprotective activity
The animals receiving different treatments were euthanized on the 13 th day and blood samples were collected by retroorbital puncturing method. The serum was separated by centrifugation at 1000 rpm for 10 min and analyzed for various biochemical parameters including serum glutamate oxaloacetate transaminases (SGOT), serum glutamate pyruvate transaminases (SGPT), alkaline phosphatase (ALP), total bilirubin (TB), triglycerides (TGs), and cholesterol using Erba Chem 5 Plus V2 biochemistry analyzer (Transasia, Germany).
Histopathological examination
Livers of rats receiving different treatments were isolated, fixed in formaldehyde (10% v/v) and histopathologically examined using hematoxylin and eosin dyes. The cellular images were captured at suitable magnification.
Indirect method (Barbiturate-induced sleep model)
This method was used for both curative and prophylactic studies. On the 13 th day, all the animals received pentobarbitone sodium (25 mg/kg body weight, i.p.) and were observed for sleep. The time interval between loss and regain of righting reflex was recorded as PST for each animal. [37, 38] Statistical analysis Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by Dunnett's t-test using Graph Pad Instat Software (Version 5.0, Graph Pad Software, San Diego, California, USA). A probability P ≤ 0.05 was considered as significant. The results were expressed as mean ± standard error of mean (n = 3) or specified in the study.
Estimation of quercetin in Z. xylopyrus leaves extracts using reversed-phase high-performance liquid chromatography (RP-HPLC)
Amount of quercetin in different extracts of Z. xylopyrus leaves was estimated by isocratic RP-HPLC (Shimadzu, Japan) comprising UV-Vis detector, RP-C18 column (250 mm × 4.6 mm, 5 µm) and spinchrome software. [39] Mixture of methanol/phosphoric acid (0.2%) (65:35 v/v) was used as the mobile phase at a flow rate of 1 mL/min at room temperature. Quercetin was quantified by UV-Vis detector following RP-HPLC separation at 360 nm.
RESULTS
Determination of Phytoconstituents
Preliminary phytochemical screening
Results of preliminary phytochemical screening were showed in Table 1 .
Estimation of TPC, TFC, and TTC
Results demonstrated that amount of TPC, TFC, and TTC differed significantly among various extracts as given in Table 2 . The TPC and TFC were found more in EAE 194.16 ± 0.74 mg GAE/g, 43.7 ± 0.78 mg QE/g of extract, respectively, while TTC was found significantly more in EtOHE 54.84 ± 1.42 mg GAE/g of extract among all the extracts. However, this method has some limitation as FCR reacts with other non-phenolic reducing compounds like organic acids, sugar leading to over evaluation of phenolic compound. [40] in vivo models International Journal of Green Pharmacy • Jan-Mar 2017 • 11 (1) | 47
Estimation of Antioxidant Activity
FRAP assay
The ferric ion reducing power of extracts was represented in Figure 1a . The reducing ability of different extracts showed following order -Vitamin C > EAE > EtOHE > PEE > CHE > AQE.
DPPH radical scavenging assay
DPPH radical scavenging assay measured hydrogen donating nature of extracts. [41] Under DPPH radical scavenging activity the inhibitory concentration 50% (IC 50 ) value of PEE, CHE, EAE, EtOHE and AQE extract was found to be 347.44 ± 2.78, 298.25 ± 1.86, 103.50 ± 2.05, 125.19 ± 1.83 and 257.02 ± 3.52 µg/mL, respectively, as compared to that of vitamin C (11.29 ± 0.66 µg/mL) [ Table 3 and Figure 1b] .
Hydroxyl radical scavenging assay
OH
• radical is one of the most reactive radicals, which has the capacity to conjugate with the nucleotides of DNA resulting in the strand breakage and leads to carcinogenesis, mutagenesis, and cytotoxicity. [26] However, the presence of antioxidant prevents the cellular damage either by quenching off or chelating transition metals.
[ Table 3 and Figure 1d ].
Superoxide radical activity assay
Superoxide anion plays an important role in the formation of other reactive oxygen species such as H 2 O 2 , OH
• and singlet oxygen, which induced oxidative damage in lipid, protein and DNA. [43] The O 2ˉ radical scavenging activity of PEE, CHE, EAE, EtOHE and AQE in terms of IC 50 value was found to be 365.43 ± 3.67, 347.44 ± 1.22, 62.03 ± 1.29, 110.47 ± 1.48 and 273.56 ± 3.29 µg/mL, respectively, as compared to that of vitamin C (34.35 ± 0.78 µg/mL). EAE exhibited significant activity in comparison to other extracts [ Table 3 and Figure 1e ].
Inhibition of lipid peroxidation assay
The PEE, CHE, EAE, EtOHE, AQE and vitamin C showed inhibition of lipid peroxidation with IC 50 value of 372.51 ± 3.84, 344.02 ± 2.89, 110.05 ± 2.96, 136.26 ± 1.76, 279.93 ± 2.81 and 71.15 ± 1.89 µg/mL, respectively [ Table 3 and Figure 1f ]. EAE extract demonstrated significant inhibition of LPO as compared to other extracts. 
Hepatoprotective Effects
In vitro hepatoprotective effect on HepG2 cell line against CCl 4 induced damage
HepG2 cell on treatment with CCl 4 (1% v/v) alone exhibited significant cell death. The cell viability was found to be 25.30 ± 1.34%. While on treatment with EAE extract along with CCl 4 , cell viability was significantly (P < 0.001) increased. The increased cell viability (maximum 89.97 ± 2.68%) was observed by increasing the concentration, i.e., at the dose of 250 µg/mL of EAE, which is comparable to standard silymarin (95.23 ± 1.66%) treatment with similar dose. The EtOHE treated cells showed only 67.37 ± 2.56% cell viability while treatment with PEE, CHE and AQE did not show the marked protective effect against CCl 4 -induced cell death [ Table 4 ].
In vivo hepatoprotective effects
Acute toxicity studies
No adverse changes and mortality were observed in animals, which orally received extracts up to 2000 mg/kg of body weight. So 1/20 th , 1/10 th and 1/5 th , i.e., 100, 200 and 400 mg/kg of body weight, respectively, of the maximum safe dose were selected for studying in vivo hepatoprotective effect.
Direct prophylactic and curative effect
Study results showed that treatment with the extract restores/ decreased the elevated serum enzyme levels produced by CCl 4 -induced hepatic damage, which might be due to cell membrane stabilization, repair of damaged hepatic tissue and/or antioxidant activity of the extract.
In case of both prophylactic and curative treatment, EAE extract more significantly (P < 0.001) decreased the elevated enzyme levels of SGOT, SGPT, ALP, TB, TG and cholesterol as compared to that of EtOHE and were found comparable to the standard control, silymarin (P < 0.001) while PEE, CHE and AQE did not exhibit marked effect on serum enzyme levels [ Tables 5 and 6 ].
The increased hepatic protection was observed by increasing the dose of the extract, which was further supported by histopathological examination [ Figures 2 and 3 ].
Indirect method (pentobarbitone-induced sleeping time [PST])
In case of both, prophylactic and curative effect, the treatment with EAE showed more significant (P < 0.001) reduction in PST in rats than that of EtOHE (P < 0.05), which was eventually comparable to that observed in silymarin treated group. On the other hand the PEE, CHE and AQE did not show any marked effect on PST [ Table 7 ]. 
Estimation of Quercetin in Z. xylopyrus Leaves Extracts Using RP-HPLC
Concentration of quercetin in various extracts has been determined by standard curve of quercetin using regression equation y = 119.4x + 45.84, r 2 = 0.998, where y is the area under peak and x is concentration. Maximum amount of the quercetin was found in EAE (32.8 ± 0.24 mg/g of dried extract) followed by EtOHE (7.2 ± 0.09 mg/g of dried extract). PEE does not contain quercetin while CHE and AQE showed the presence of small amount of quercetin [ Table 8 and Figure 4 ]. 
DISCUSSION
Oxidative stress is a result of physiological imbalance between pro-oxidant and antioxidant disruption. [1] However, biological system of our body protects us against free radical and ROS-induced damage via endogenous production of antioxidant enzymes such as catalase, glutathione peroxidase, superoxide dismutase and antioxidant nutrients such as ascorbic acid, α-tocopherol and glutathione. [27] However, the overproduction of ROS or imbalance between system's ability to detoxify toxic intermediate or repair the damage plays a vital role in LPO, which leads to hepatic dysfunction. [42] Therefore the present study was designed to investigate the hepatoprotective potential of different extract of Z. xylopyrus leaves against CCl 4 -induced toxicity by in vitro and in vivo models. Polyphenols are the major category of phytoconstituents with antioxidant activity, which is mainly attributed due to their redox properties, i.e. absorbing and neutralizing free radicals, quenching singlet and triplet oxygen species, or decomposing peroxides. [28, 44] Preliminary phytochemical screening results showed the presence of alkaloids, flavonoids, tannins, terpenoids, steroids and carbohydrate in various extracts of Z. xylopyrus while EAE showed the presence of flavonoids, tannins, steroids, and terpenoids. These compounds have been previously reported to possess antioxidant as well as hepatoprotective potential. [44] In this study, chain reaction by donating hydrogen atom. The marked antioxidant activity of EAE was probably due to the presence of phenolic components, which acted as reductants, i.e. due to its hydrogen donating nature. [26] The EAE significantly reduced LPO induced by FeCl 2 -H 2 O 2 (IC 50 110.05 ± 2.96 µg/mL). The LPO inhibition capacity of the extract might be due to OH• radical scavenging activity of the extract, which might be due to presence of polyphenols (TPC 194.16 ± 0.74 mg GAE/g of dried extract and TFC 43.76 ± 0.78 mg QE/g of dried extract), possessing phenolic hydroxyl groups, have the ability to accept electrons or combines with free radicals competitively to decrease lipid peroxidation induced by free radicals. [28, 33] Normal hepatocytes are used as in vitro model for studying the in vitro xenobiotics metabolism and toxicity to the liver. [4] In this study, HepG2 cells were used that minimized any species related differences and maintained majority of specialized function like cell viability, which directly referred the extracellular stress response. Among all the extracts, EAE significantly inhibited the ROS in a dose-dependent manner (IC 50 80.93 ± 1.02 µg/mL), which was comparable to silymarin (IC 50 76.11 ± 0.96 µg/mL) and resulted in increased cell viability.
Carbon tetrachloride, widely used xenobiotics is metabolized by the liver and produces free radicals (CCl 3 • and OOCCl 3 •), which interfere with the transportation function of the hepatic cells and also react with cellular lipid as well as proteins in the presence of oxygen that leads to leakage of SGOT, SGPT from the cell cytoplasm in serum. The CCl 4 also impairs the excretion of bile from pancreas and consequently increases serum ALP and TB level and altered the cholesterol metabolism and TGs transportation causing increased TG and cholesterol levels leading to fatty liver. [45] [46] [47] CCl 4 increased the level of Ca 2+ in cells, which activated many catabolic enzymes, which destroyed the cytoskeletal construction and cell death through apoptosis or necrosis. [48] In case of both, direct prophylactic and curative study, treatments with EAE (400 mg/kg body weight) significantly preserved the levels of SGOT, SGPT, ALP, TB, TG and cholesterol depicting a marked protective effect in a dose-dependent manner comparable to silymarin treatment.
Damage inflicted by CCl 4 on hepatocytes also caused the loss of microsomal drug metabolizing enzyme of the liver, which resulted in the prolongation of PST. In indirect prophylactic and curative study, treatment with EAE (400 mg/kg) showed a significant reduction in PST, which might be due to improved metabolic capacity of hepatic cells. [36] The histopathological images depicted that CCl 4 -induced the hepatic damage with complete loss of normal cellular structures. The cell hypertrophy, damage in central lobular vein, blood infiltration, fatty changes even necrosis was observed. Histopathological studies provided conclusive evidence that EAE possessed the ability to counteract the CCl 4 -induced cytotoxic effects, and advocated the hepatoprotective potential of Z. xylopyrus leaves.
On RP-HPLC analysis, the highest content of quercetin (32.8 ± 0.24 mg/g of dry weight of extract) was found to be in EAE followed by EtOHE (7.2 ± 0.09 mg/g in dry weight).
Quercetin is a leading compound for developing the new and effective functional food or medicine due to its remarkable scope of health benefits like antioxidant activities, antiinflammatory, anti-allergic, anti-cancer, cardioprotective, and hepatoprotective activities. [49] Quercetin showed strong antioxidant activity not only from accepting oxygen free radicals but also by forming metal chelation compounds. [50] The high amount of quercetin present in EAE attenuated the inflammation by down-regulating the CCl 4 -induced activation of nuclear factor-kappa B, tumor necrosis factor-α and cyclooxygenase and showed hepatoprotective effects. [51] 
CONCLUSION
The results of in vitro and in vivo studies clearly demonstrated the effectiveness of EAE in attenuation of CCl 4 -induced liver damage, possibly by reducing the oxidative stress and inflammation reflecting its antioxidant activity due to the presence of flavonoids mainly quercetin and other polyphenolic compounds. This study provided experimental evidence, which clearly justified the traditional claims and uses of Z. xylopyrus against oxidative liver disease. Since the plant contained quercetin as main active compound along with other polyphenols including flavonoids responsible for hepatoprotective activity as shown by marked antioxidant potential as evidenced by different free radical scavenging assays. Further, the plant extracts were found safe up to 2000 mg/kg body weight in treated rats as witnessed by in vivo studies. Hence, we recommend that the Z. xylopyrus can be considered for the development of functional food or herbal hepatoprotective medicine after carrying out pre-clinical evaluation and long-term toxicity studies.
